Analysis | Samples | Factors | Units |
---|---|---|---|
Reversed phase POSITIVE ION MODE | ASPC-C-1 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-C-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-C-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-C-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-C-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-GI-1 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-GI-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-GI-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-GI-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-GI-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-G-1-r002 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-G-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-G-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-G-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-G-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-C-1 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-C-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-C-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-C-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-C-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with 25μl DMSO for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-GI-1 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-GI-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-GI-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-GI-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-GI-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM and IBMX with a final concentration of 200μM for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-G-1-r002 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-G-2 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-G-3 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-G-4 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-G-5 | Treatment:After inoculating cells for 24h in 10cm dishes, treating cells with gemcitabine with a final concentration of 50μM for 72h | counts |